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Introduction: Dengue is a viral disease that spreads rapidly in the tropic and subtropic regions of the world and
causes 22,000 deaths annually. In 2009, the World Health Organization (WHO) released a new classification of
dengue infections, which divided them into three categories: dengue without warning sign (D), dengue with
warning sign (DWS), and severe dengue (SD). However, researchers have been using different criteria to define
persistent vomiting; therefore, we aimed to evaluate the ability of the number of vomiting times in early prediction
of SD development among D/DWS patients.
Method: A hospital-based cohort study was conducted in Ben Tre-south of Vietnam. We enrolled confirmed
dengue patients with D and DWS at admission. The final classification was determined on the discharged day for
every patient based on the classification of WHO 2009 without using vomiting symptom, using the receiver
operating characteristic (ROC) curve to evaluate the ability of the number of vomiting times in early prediction of
SD development among D/DWS patients.
Result: The prevalence of vomiting symptom was higher in SD group than D/DWS group (92 versus 46 %, p = 0.006),
and the median of the number of vomiting times was higher in SD group than D/DWS group (2.5 versus 0, p = 0.001).
To distinguish SD from D/DWS, the ROC curve of the number of vomiting episodes showed that the area under the
curve was 0.77; with the cut point of two, the sensitivity and specificity were 92 and 52 %, respectively.
Conclusion: The number of vomiting times could be a good clinical sign which can early predict SD from the group
of D/DWS. We suggest the definition of persistent vomiting should be vomiting two times or more per day.
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Dengue is a re-emerging vector-borne viral disease that
spreads rapidly in the tropic and subtropic regions of the
world, caused by dengue virus. The World Health
Organization (WHO) estimates a mortality rate of
dengue infection between 1 and 5 %, mainly among
children with shock. Among 500,000 cases of dengue
hemorrhagic fever, 22,000 deaths occur annually [1–3].* Correspondence: tienhuy@nagasaki-u.ac.jp
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The classification of 2009 WHO guideline of dengue
infections into three categories (dengue without warning
sign (D), dengue with warning sign (DWS), and severe
dengue (SD)) has clear advantages in research, epidemi-
ology, and clinical use [5]. Early detection of the individ-
uals who will develop SD among D/DWS patients is
very important for timely clinical management. However,
among the warning signs, the literature and the 2009
WHO guideline of dengue infections do not provide a
clear criterion of persistent vomiting. Many authors usedis distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 ROC curve of the number of vomiting episodes for predicting
SD development among D/DWS patients
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than five times in 6 h or more than three times in 1 h,
or vomiting during two or more consecutive days, or
more than three episodes of vomiting in 12 h [6–8].
Hence, we conducted a study in Vietnam to evaluate the
ability of the number of vomiting episodes in early pre-
diction of SD development among D/DWS patients and
then to suggest a criterion for persistent vomiting.
Methods
This was a hospital-based cohort study taking place in
Nguyen Dinh Chieu hospital in Ben Tre province, south
of Vietnam, from June 2011 to November 2013.
The study was approved by Institutional Review Board
of Institute of Tropical Medicine (NEKKEN), Nagasaki
University (No.11063072), and the Pasteur Institute in
Ho Chi Minh City (PIHCM) (No.602/QD-Pas 27/12/10).
Informed consent was taken from patients, and if the
patient was under 18 years old, informed consent was
given by a parent or guardian. Patients were eligible for
enrollment when they were hospitalized with diagnosis
of dengue fever, acute onset fever (≥38 °C) for less than
72 h, and without severe symptoms before hospitalization.
Dengue infection was confirmed by positive serologic
assays, virus isolation, or reverse transcription polymerase
chain reaction (RT-PCR) for the identification of viral
serotype, as described in our previous studies [9, 10]. All
the signs including the warning signs which are descrip-
tive in the WHO 2009 classification [11] were collected
before admission till discharge from the hospital. All the
patients were in D/DWS group when admission, and they
were followed until discharge to determine whether they
would develop to SD. The final diagnosis was determined
on the discharged day for every patient based on the clas-
sification of WHO 2009 without using vomiting symptom,
using the receiver operating characteristic (ROC) curve
for these two groups to evaluate the ability of the number
of vomiting times in early prediction of SD development
among D/DWS patients. Stata 12.0 was used for analyzing
the study data.
Results
There were 79 patients participated in this study.
Among them, female ratio was 51 % (40/79); the median
(inter quartile range, IQR) of age was 14 (11–19) years.
According to the 2009 WHO classification, the patients
with final D/DWS/SD diagnosis were 32/35/12 (41, 44,
and 15 %, respectively). The most three frequent clinical
signs were vomiting (n = 44, 56 %), abdominal pain or
tenderness (n = 35, 44 %), and skin bleeding (n = 30,
38 %). Most of the patients had secondary infection
(n = 63, 80 %). When comparing the vomiting sign in
the two groups (D/DWS versus SD), the frequency of
vomiting sign was significantly higher among patientsin SD group (92 %, 11/12) than among patients in D/
DWS group (49 %, 33/67); p = 0.013 (chi-square test).
In addition, the median (IQR) of the number of
vomiting episodes per day was significantly higher in
SD group (2.5, 2–3) than in D/DWS group (0, 0–2);
p = 0.001 (Mann-Whitney test). Figure 1 shows the
ROC curve of the number of vomiting episodes per
day when predicting SD, the area under the ROC
curve is 0.77. In the cut point of two, the sensitivity
and specificity were 92 and 52 %, respectively. With
this cut point, we had 43 patients (54 %) with persist-
ent vomiting in this study and we found this warning
sign to be associated with the development of SD
(odds ratio (OR) 12.0; 95 % confident interval (95 %
CI) 1.5–532.2).
Discussion
In this study, vomiting was the most frequent clinical
symptom. This is a popular symptom which can be easy
to recognize and monitor, even by the patients. When
comparing the vomiting sign in the two groups (D/DWS
versus SD), SD group had significantly higher prevalence
of vomiting sign and also higher median of the number
of vomiting episodes. Therefore, vomiting sign could be
a good clinical sign which can early predict SD develop-
ment among D/DWS patients. Indeed, the ROC curve of
the number of vomiting episodes per day when predict-
ing SD among D/DWS patients had the good area under
the curve, which was 0.77. With good sensitivity, the
chosen cut point of the number of vomiting episodes
per day is two, of which the sensitivity and specificity are
92 and 52 %, respectively. With this cut-point value, we
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the development of SD (OR 12.0 (95 % CI 1.5–532.2));
this result is similar to Thanachartwet et al. (OR 4.817
(95 % CI 1.375–16.873)) [12]. With patients diagnosed
of dengue infection with acute onset fever (≥38 °C) for
less than 72 h, when the patient vomits two times or
more per day, clinician should carefully follow up him/
her because this patient may early turn into SD accord-
ing to 2009 WHO classification. Therefore, our research
suggests a criterion for persistent vomiting should be
vomiting two times or more per day. Further, large stud-
ies are required to validate this criterion.
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